Endothelin antagonism in experimental hepatic fibrosis: Implications for endothelin in the pathogenesis of wound healing

Journal of Clinical Investigation

Volumn 98, Issue 6, 1996, Pages 1381-1388

  Rockey, Don C ^a   Chung, John J ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

bosentan; lipocyte; liver; sarafotoxin; stellate cell

Indexed keywords

BOSENTAN; ENDOTHELIN; SARAFOTOXIN;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; DRUG ANTAGONISM; EXTRACELLULAR MATRIX; FIBROGENESIS; LIVER FIBROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; STELLATE CELL; T LYMPHOCYTE ACTIVATION; WOUND HEALING;

EID: 0029766854     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118925     Document Type: Article

References (42)

1. Bissell, D.M. 1990. Connective tissue metabolism and hepatic fibrosis: an overview. Sem. Liver Dis. 10:iii-iiv.
2. Friedman, S.L. 1993. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N. Engl. J. Med. 328:1828-1835.
3. Rockey, D.C., J.K. Boyles, G. Gabbiani, and S.L. Friedman. 1992. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J. Submicrosc. Cytol. Pathol. 24:193-203.
4. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells [see comments]. Nature (Lond.). 332:411-415.
5. Luscher, T.F. 1991. Endothelin. J. Cardiovasc. Pharmacol. 18 (Suppl. 10): S15-S22.
6. Goto, K., and T.D. Warner. 1995. Molecular pharmacology. Endothelin versatility. Nature (Lond.). 375:539-540.
7. Baynash, A.G., K. Hosoda, A. Giaid, J.A. Richardson, N. Emoto, R.E. Hammer, and M. Yanagisawa. 1994. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell. 79:1277-1285.
8. Clozel, M., V. Breu, G.A. Gray, B. Kalina, B.M. Loffler, K. Burri, J.M. Cassai, G. Hirth, M. Muller, and W. Neidhart. 1994. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 270:228-235.
9. Ohlstein, E.H., P. Nambi, S.A. Douglas, R.M. Edwards, M. Gellai, A. Lago, J.D. Leber, R.D. Cousins, A. Gao, and J.S. Frazee. 1994. SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. Proc. Natl. Acad. Sci. USA. 91:8052-8056.
10. Gandhi, C.R., K. Stephenson, and M.S. Olson. 1990. Endothelin, a potent peptide agonist in the liver. J. Biol. Chem. 265:17432-17435.
11. Gandhi, C.R., R.H. Behal, S.A. Harvey, T.A. Nouchi, and M.S. Olson. 1992. Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes. Biochem. J. 287:897-904.
12. Stephenson, K., S.A. Harvey, S.B. Mustafa, A.T. Eakes, and M.S. Olson. 1995. Endothelin association with the cultured rat Kupffer cell: characterization and regulation. Hepatology. 22:896-905.
13. Jouneaux, C., A. Mallat, C. Serradeil-Le Gal, P. Goldsmith, J. Hanoune, and S. Lotersztajn. 1994. Coupling of endothelin B receptors to the calcium pump and phospholipase C via Gs and Gq in rat liver. J. Biol. Chem. 269:1845-1851.
14. Housset, C., D.C. Rockey, and D.M. Bissell. 1993. Endolhelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc. Natl. Acad. Sci. USA. 90:9266-9270.
15. Rockey, D.C. 1995. Characterization of endothelin receptors mediating rat hepatic stellate cell contraction. Biochem. Biophys. Res. Commun. 207:725-731.
16. Rockey, D.C., C.N. Housset, and S.L. Friedman. 1993. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J. Clin. Invest. 92:1795-1804.
17. Moore, K., J. Wendon, M. Frazer, J. Karani, R. Williams, and K. Badr. 1992. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N. Engl. J. Med. 327:1774-1778.
18. Leivas, A., W. Jimenez, S. Lamas, M. Bosch-Marce, J. Oriola, J. Claria, V. Arroyo, F. Rivera, and J. Rodes. 1995. Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites. Gastroenterology. 108:1842-1848.
19. Housset, C. A. Laudat, J.J. Chung, and D.C. Rockey. 1995. Expression and potential role of endothelin in cholestatic liver injury. Hepatology. 22:278.
20. Kountouras, J., B.H. Billing, and P.J. Scheuer. 1984. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br. J. Exp. Pathol. 65:305-311.
21. de Leeuw, A.M., S.P. McCarthy, A. Geerts, and D.L. Knock. 1984. Purified rat liver fat-storing cells in culture divide and contain collagen. Hepatology. 4:392-403.
22. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
23. Jarnagin, W.R., D.C. Rockey, V.E. Koteliansky, S.S. Wang, and D.M. Bissell. 1995. Expression of variant fibronectins in wound healing. J. Cell Biol. 127:2037-2048.
24. Maher, J.J., and R.F. McGuire. 1990. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J. Clin. Invest. 86:1641-1648.
25. Melton, D.A., P.A. Krieg, M.R. Rebagliati, T. Maniatis, K. Zinn, and M.R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:7035-7056.
26. Malkusch, W., B. Rehn, and J. Bruch. 1995. Advantages of Sirius Red staining for quantitative morphometric collagen measurements in lungs. Exp. Lung Res. 21:67-77.
27. Matsuoka, M., N.T. Pham, and H. Tsukamoto. 1989. Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver. 9:71-78.
28. Friedman, S.L., F.J. Roll, J. Boyles, D.M. Arenson, and D.M. Bissell. 1989. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J. Biol. Chem. 264:10756-10762.
29. Jaffer, F.E., T.C. Knauss, E. Poptic, and H.E. Abboud. 1990. Endothelin stimulates PDGF secretion in cultured human mesangial cells. Kidney. Int. 38: 1193-1198.
30. Nakatsukasa, H., P. Nagy, R.P. Evarts, C.C. Hsia, E. Marsden, and S.S. Thorgeirsson. 1990. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J. Clin. Invest. 85:1833-1843.
31. Saperstein, L.A., R.L. Jirtle, M. Farouk, H.J. Thompson, K.S. Chung, and W.C. Meyers. 1994. Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology. 19:412-417.
32. Mallat, A., L. Fouassier, A.M. Preaux, C.S. Gal, D. Raufaste, J. Rosenbaum, D. Dhumeaux, C. Jouneaux, P. Mavier, and S. Lotersztajn. 1995. Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. J. Clin. Invest. 96:42-49.
33. Battistini, B., P. Chailler, P. D'Orleans-Juste, N. Briere, and P. Sirois. 1993. Growth regulatory properties of endothelins. Peptides. 14:385-399.
34. Fujitani, Y., H. Ninomiya, T. Okada, Y. Urade, and T. Masaki. 1995. Suppression of endothelin-1-induced mitogenic responses of human aortic smooth muscle cells by interleukin-1 beta. J. Clin. Invest. 95:2474-2482.
35. Gabbiani, G., G.B. Ryan, and G. Majne. 1971. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia. 27:549-550.
36. Kuhn, C., and J.A. McDonald. 1991. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am. J. Pathol. 138:1257-1265.
37. Sappino, A.P., W. Schurch, and O. Gabbiani. 1990. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab. Invest. 63:144-161.
38. Appleton, I., A. Tomlinson, C.L. Chander, and D.A. Willoughby. 1992. Effect of endothelin-1 on croton oil-induced granulation tissue in the rat. A pharmacologic and immunohistochemical study. Lab. Invest. 67:703-710.
39. Giaid, A., R.P. Michel, D.J. Stewart, M. Sheppard, B. Corrin, and Q. Hamid. 1993. Expression of endolhelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet. 341:1550-1554.
40. Giaid, A., D. Saleh, M. Yanagisawa, and R.D. Forbes. 1995. Endothelin-1 immunoreactivity and mRNA in the transplanted human heart. Transplantation (Baltimore). 59:1308-1313.
41. Simonson, M.S., and W.H. Herman. 1993. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. Cross-talk between G protein-coupled receptors and pp60c-src. J. Biol. Chem. 268:9347-9357.
42. Katwa, L.C., E. Guarda, and K.T. Weber. 1993. Endothelin receptors in cultured adult rat cardiac fibroblasts. Cardiovasc. Res. 27:2125-2129.